VTv Therapeutics wins FDA orphan designation for HPPD in sickle cell
VTv Therapeutics said the FDA granted orphan drug designation to HPPD, being investigated as a treatment for sickle cell disease.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.